BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16698422)

  • 1. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection.
    Migita K; Abiru S; Maeda Y; Daikoku M; Ohata K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
    Hum Immunol; 2006; 67(1-2):27-32. PubMed ID: 16698422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
    Hasegawa M; Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
    J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.
    Nagaoka T; Sato S; Hasegawa M; Ihn H; Takehara K
    J Rheumatol; 2000 Aug; 27(8):1917-21. PubMed ID: 10955333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome.
    Robinson M; Gray SR; Watson MS; Kennedy G; Hill A; Belch JJ; Nimmo MA
    Scand J Med Sci Sports; 2010 Apr; 20(2):282-90. PubMed ID: 19422646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of interleukin-6 and its soluble receptors by activated peripheral blood monocytes is elevated in hypocholesterolemic hemodialysis patients.
    Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Ioannou D; Fatourou A; Nicolaou C
    Am J Nephrol; 2005; 25(5):484-90. PubMed ID: 16127269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Examination and evaluation of sIL-6R, sgp130 in serum in patients with chronic hepatopathy].
    Shang J; Xu Y; Zhang H
    Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):87-8. PubMed ID: 10861111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence risk.
    Pulsatelli L; Boiardi L; Pignotti E; Dolzani P; Silvestri T; Macchioni P; Cantini F; Salvarani C; Facchini A; Meliconi R
    Arthritis Rheum; 2008 Aug; 59(8):1147-54. PubMed ID: 18668607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure.
    Hirota H; Izumi M; Hamaguchi T; Sugiyama S; Murakami E; Kunisada K; Fujio Y; Oshima Y; Nakaoka Y; Yamauchi-Takihara K
    Heart Vessels; 2004 Sep; 19(5):237-41. PubMed ID: 15372299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of serum soluble interleukin-6 receptor and soluble gp130 levels in patient with pregnancy induced hypertension and its significance].
    Li Y; Wang Y; Qi L
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):18-9. PubMed ID: 11778537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD.
    Memoli B; Grandaliano G; Soccio M; Postiglione L; Guida B; Bisesti V; Esposito P; Procino A; Marrone D; Michael A; Andreucci M; Schena FP; Pertosa G
    J Am Soc Nephrol; 2005 Apr; 16(4):1099-107. PubMed ID: 15716332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease.
    Ludwiczek O; Vannier E; Moschen A; Salazar-Montes A; Borggraefe I; Gabay C; Enrich B; Kaser A; Siegmund B; Dinarello C; Tilg H
    Scand J Gastroenterol; 2008; 43(11):1360-5. PubMed ID: 18609176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interleukin-6 and its soluble receptors in human breast cancer].
    Kuang Y; Zhang Z; Zhang X
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):305-7. PubMed ID: 10920992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
    Bagli M; Papassotiropoulos A; Hampel H; Becker K; Jessen F; Bürger K; Ptok U; Rao ML; Möller HJ; Maier W; Heun R
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):44-8. PubMed ID: 12664314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The levels of IL-1beta, IL-4 and IL-6 in the serum and the liver tissue of chronic HCV-infected patients.
    Lapiński TW
    Arch Immunol Ther Exp (Warsz); 2001; 49(4):311-6. PubMed ID: 11726034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE
    Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
    Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
    Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of serum soluble interleukin-2 receptor levels in patients with hepatitis C virus infection.
    Kawakami Y; Hayashi J; Ueno K; Ohmiya M; Kishihara Y; Yamaji K; Kashiwagi S
    Fukuoka Igaku Zasshi; 1997 Jul; 88(7):274-82. PubMed ID: 9267073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV infection in haemodialysed patients: a role for serum IL-10 and TGF-beta1 in liver damage?
    Burra P; Masier A; Morisco F; Di Leo V; Zorzi M; Senzolo M; Marchini F; Guido M; Canova D; Floreani A; Burroughs AK
    Dig Liver Dis; 2008 Oct; 40(10):827-33. PubMed ID: 18372225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor.
    De Jongh R; Vranken J; Vundelinckx G; Bosmans E; Maes M; Heylen R
    Cytokine; 1997 Sep; 9(9):696-701. PubMed ID: 9325019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.